SLC6A3 and Cognitive impairment: Additionalfeatures were observed in some cases, including early onset and rapid progression (CaseI-1), cognitive impairment (Cases III-1 and VI-1), muscle cramps (Cases I-1, II-1, III-1and IV-1) and REM sleep behaviour disorder with positive dopamine transporter scan(DatScan) (Case IX-1).